Fishy data

Fishy data

Author: The BMJ August 27, 2013 Duration: 19:58

Rajiv Chowdury, a research associate from the Department of Public Health and Primary Care at the University of Cambridge, explains why eating whole fish is better than fish oil - at least when it comes to cerebrovascular disease. Also this week Peter Doshi and Tom Jefferson from the Cochrane Collaboration talk about the BMJ's open data campaign, and how publishing correspondence with Roche, the WHO and Centers for Disease Control and Prevention might reveal the missing data on Tamiflu.


Produced by The BMJ, this weekly audio series delves into the pivotal research and urgent clinical debates shaping modern medicine. Each episode moves beyond the published page, bringing together the authors, critics, and practitioners directly involved to dissect a new study or a pressing health question. The conversation is rigorous and nuanced, designed for those who appreciate the complexity behind headlines. You’ll hear unscripted discussion about methodology, implications for practice, and the occasional healthy disagreement that drives science forward. This isn't just a summary of the latest findings; it's a critical appraisal in real time, offering listeners a front-row seat to the evolving discourse that defines evidence-based care. The Medicine and Science from The BMJ podcast serves as an essential audio companion for clinicians, academics, and anyone keen to understand the ‘why’ and ‘how’ behind medical news. It transforms the latest evidence from the journal into an accessible, thought-provoking dialogue, ensuring that busy professionals can stay deeply informed. Tune in for a direct, intelligent, and often surprising take on the science that matters most.
Author: Language: English Episodes: 1000

Medicine and Science from The BMJ
Podcast Episodes
The misunderstanding of overdiagnosis [not-audio_url] [/not-audio_url]

Duration: 28:15
In December 2017, the NEJM’s national corespondent, Lisa Rosenbaum, published an article “The Less-Is-More Crusade — Are We Overmedicalizing or Oversimplifying?” The article aimed a broadside against those who are campai…
Biochem for kids [not-audio_url] [/not-audio_url]

Duration: 22:35
Each time you order a test for a child, do you think the population that makes up the baseline against which the results are measured? It turns out that that historically those reference intervals have been based on adul…
Antidepressants and weight gain [not-audio_url] [/not-audio_url]

Duration: 17:03
Patients who are depressed and prescribed antidepressants may report weight gain, but there has been limited research into the association between the two. However new observational research published on bmj.com aims to…
Think of healthcare is an ecosystem, not a machine [not-audio_url] [/not-audio_url]

Duration: 37:01
Complexity science offers ways to change our collective mindset about healthcare systems, enabling us to improve performance that is otherwise stagnant, argues Jeffrey Braithwaite, professor of health systems research an…
New antivirals for Hepatitis C - what does the evidence prove? [not-audio_url] [/not-audio_url]

Duration: 16:41
There’s been a lot of attention given to the new antirviral drugs which target Hepatitis C - partly because of the burden of infection of the disease, and the lack of a treatment that can be made easily accessible to aro…
What forced migration can tell us about diabetes [not-audio_url] [/not-audio_url]

Duration: 23:08
Worldwide, the rate of type II diabetes is estimated to be around 1 in 11 people - about 9%. For the Pima people of Arizona, 38% of the adult population have the condition - but across the border in Mexico, the rate drop…
Big Metadata [not-audio_url] [/not-audio_url]

Duration: 19:47
We’re in an era of big data - and hospitals and GPs are generating an inordinate amount of it that has potential to improve everyone’s health. But only if it’s used properly. New research published on www.bmj.com this we…
WHO can tackle pharma advertising [not-audio_url] [/not-audio_url]

Duration: 26:13
The array of options available to pharmaceutical companies, to advertise their drugs, is incredibly broad - and the amount that they spend is increasing, with some reports saying it’s up 60% in the last five years. In mo…
The complexities of depression in cancer [not-audio_url] [/not-audio_url]

Duration: 37:34
For many people, cancer is now survivable and has become a long term condition, and depression and anxiety are more common in cancer survivors than in the general population. Despite this, 73% of patients don't receive e…
E-cigarettes - debating the evidence [not-audio_url] [/not-audio_url]

Duration: 32:45
Smokers want to vape, it can help them quit, and it’s less harmful than smoking, say Paul Aveyard professor of behavioural medicine at the University of Oxford. But Kenneth C Johnson, adjunct professor at the University…